Annual report pursuant to Section 13 and 15(d)

Supplemental Disclosure of Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details)

v3.21.1
Supplemental Disclosure of Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash paid for interest $ 64,454
Cash paid for income taxes 45,000
Series I-2 Preferred Stock converted into common stock 277,994 1,268,972
Issuance of Series M Preferred Stock in exchange for related party loans and accrued interest 22,000,000
Loans and accrued interest exchanged for Series M Preferred Stock 18,849,632
Issuance of Series N Preferred Stock in exchange for debentures, accrued interest and Series I-1 and Series I-2 Preferred Stock 30,435,519
Debentures, accrued interest and Series I-1 and Series I-2 Preferred Stock exchanged for Series N Preferred Stock 19,342,322
Series N Preferred Stock converted into common stock 1,001,000
Deemed dividends from exchanges of debt for preferred stock 6,871,086  
Deemed dividends from down-round provisions of warrants and debentures 256,383,632 123,861,587
Common stock issued in cashless exercise of warrants 11,962
Exchange of Series K Preferred Stock for Series L Preferred Stock (2,500)
Issuance of Series L Preferred Stock 2,500
Original issue discounts on debt 122,885 400,000
Acquisition of Jellico Community Hospital and CarePlus Center [Member]    
Inventory 317,427
Property and equipment 500,000
Intangible assets 250,000
Accrued expenses $ 158,890